WHAT WE DO
Basin Genomics is soon to be offering a cutting-edge test for oral cancer that provides early detection of precancerous cellular changes. By leveraging novel research, our breakthrough technology will have the ability to differentiate between grades of cancer by molecular signature in order to assist clinicians in selecting the most appropriate treatment options for their patients.
WHO WE ARE
Basin Genomics is a growing team of scientists, patient advocates, and entrepreneurs committed to advancing the fight against oral cancer. Founded in 2018, our goal it is to increase accessibility and efficacy of HPV testing to improve health outcomes on a global scale.